Showing results (51-60 of 167) with videos related to

Sort By:
Pageof 17
Plos One|March 1, 2023
Racial differences in prevention decision making among U.S. women at high risk of breast cancer: A qualitative studyTasleem J Padamsee, Anna Muraveva, Rachel J Meadows, et al.
Onkologie|February 8, 2012
Borderline tumors of the ovary: clinical course and prognostic factorsNina Ewald-Riegler, Oya du Bois, Annette Fisseler-Eckhoff, et al.
Cell Reports|December 16, 2016
Id3 Maintains Foxp3 Expression in Regulatory T Cells by Controlling a Transcriptional Network of E47, Spi-B, and SOCS3Katharina S Rauch, Miriam Hils, Ekaterina Lupar, et al.
Journal of Thrombosis and Haemostasis : JTH|October 4, 2019
Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)Ralf Pasternack, Christian Büchold, Robert Jähnig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Requirements to assess feasibility of phase 0 trials during major abdominal surgery: variability of PARP activityFlorian Heitz, Andreas du Bois, Justine Rochon, et al.
Gynecologic Oncology|January 28, 2014
Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancerPhilipp Harter, Bianca Beutel, Piero F Alesina, et al.
International Journal of Molecular Sciences|July 14, 2023
The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug TreatmentJorma Isola, Markku Mäki, Martin Hils, et al.
Scientific Reports|September 28, 2016
In-vivo, non-invasive detection of hyperglycemic states in animal models using mm-wave spectroscopyPedro Martín-Mateos, Fabian Dornuf, Blanca Duarte, et al.
Gynecologic Oncology|March 19, 2011
Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancerPhilipp Harter, Zelal M Muallem, Christine Buhrmann, et al.
Pageof 17